Norway, May 13 -- Thor Medical ASA, a leading emerging supplier of alpha-emitters for next-generation precision cancer treatment, has signed an agreement securing supply of thorium feedstock from a major European multinational chemical manufacturing company.The three-year supply agreement strengthens the already strong partnership between the two companies and secures feedstock supplies for Thor Medical's production of radioisotopes at its current pilot plant and its commercial scale plant under construction, AlphaOne. Thor Medical has already signed sales agreements with several radiopharmaceutical companies with late-stage cancer therapeutic candidates based on alpha-emitting lead-212 isotopes.The supply agreement with the undisclosed par...